Chiusura precedente | 107,27 |
Aperto | 111,03 |
Denaro | 0,00 x 0 |
Lettera | 0,00 x 0 |
Min-Max giorno | 111,03 - 111,09 |
Intervallo di 52 settimane | 111,03 - 111,09 |
Volume | |
Media Volume | N/D |
Capitalizzazione | 83,957M |
Beta (5 anni mensile) | 1,15 |
Rapporto PE (ttm) | 0,34 |
EPS (ttm) | 3,29 |
Prossima data utili | 02 nov 2022 - 07 nov 2022 |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
WATERTOWN, Mass., June 23, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the election of Anthony (Tony) Adamis, M.D. to its Board of Directors. Dr. Adamis is a highly accomplished ophthalmology executive with more than 30 years of research and development experience in the biopharmaceutical industry. “Dr. Adamis i
Southern California Native Jewelry Brand, gorjana, Set to Join Bethesda Row and M Street Georgetown Neighborhoods gorjana Bethesda Store gorjana expands its retail footprint with a new storefront in Bethesda gorjana Georgetown Store gorjana expands its retail footprint with a new storefront in Georgetown WASHINGTON, Oct. 15, 2021 (GLOBE NEWSWIRE) -- gorjana, the popular Laguna Beach based jewelry brand, announces the brand is headed to the D.C. Metro area with two new storefronts in Georgetown a